4/17
08:31 am
regn
Rating for REGN
Low
Report
Rating for REGN
4/14
02:02 pm
regn
Rating for REGN
Low
Report
Rating for REGN
4/14
02:02 pm
regn
Rating for REGN
Low
Report
Rating for REGN
4/14
02:02 pm
regn
Rating for REGN
Low
Report
Rating for REGN
3/31
10:34 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
09:25 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
09:25 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
07:17 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
07:16 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $834.00 price target on the stock, up previously from $762.00.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $834.00 price target on the stock, up previously from $762.00.
2/5
06:10 am
regn
Regeneron upgraded to Outperform from Market Perform at Leerink
Low
Report
Regeneron upgraded to Outperform from Market Perform at Leerink
1/28
07:28 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/28
07:28 am
regn
Rating for REGN
Low
Report
Rating for REGN